Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.855 USD | +5.35% | -9.36% | -60.01% |
Financials (USD)
Sales 2024 * | 13.6M | Sales 2025 * | 18.72M | Capitalization | 3.12M |
---|---|---|---|---|---|
Net income 2024 * | -5M | Net income 2025 * | - | EV / Sales 2024 * | 0.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-7.74
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on NovaBay Pharmaceuticals, Inc.
1 day | +4.61% | ||
1 week | -9.36% | ||
Current month | -17.00% | ||
1 month | +1.46% | ||
3 months | -41.86% | ||
6 months | -71.11% | ||
Current year | -60.01% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 2.855 | +5.35% | 69 073 |
24-06-07 | 2.71 | -9.06% | 120,621 |
24-06-06 | 2.98 | +5.30% | 172,546 |
24-06-05 | 2.83 | -1.74% | 90,985 |
24-06-04 | 2.88 | -8.57% | 183,238 |
Delayed Quote Nyse, June 10, 2024 at 03:23 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.01% | 3.12M | |
+49.72% | 57.87B | |
+41.65% | 40.25B | |
-6.92% | 39.94B | |
-5.96% | 28.54B | |
+13.07% | 26.4B | |
-19.86% | 19.33B | |
+31.83% | 12.4B | |
+0.18% | 12.23B | |
+25.45% | 12.2B |
- Stock Market
- Equities
- NBY Stock